Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:chemical_compound
|
| gptkbp:administered_by |
oral medication
|
| gptkbp:chemical_formula |
C12 H12 N2 O3 S
|
| gptkbp:clinical_trial |
Phase 2
|
| gptkbp:developed_by |
gptkb:Aprea_Therapeutics
|
| https://www.w3.org/2000/01/rdf-schema#label |
APR-246
|
| gptkbp:indication |
gptkb:myelodysplastic_syndromes
gptkb:Oncology |
| gptkbp:mechanism_of_action |
restores function of mutant p53
|
| gptkbp:targets |
p53 protein
|
| gptkbp:used_in |
gptkb:cancer_treatment
|
| gptkbp:bfsParent |
gptkb:Aprea_Therapeutics
|
| gptkbp:bfsLayer |
6
|